Published 07/26/2024 4:10:00 p.m.

[Opinion] EMA has not approved lekanemab

Summary by delo.si

Europeans continue to be deprived of a new drug for Alzheimer's disease, as the European Medicines Agency gave a negative opinion.

0 Articles

All

Left

Center

Right

Europeans continue to be deprived of a new drug for Alzheimer's disease, as the European Medicines Agency gave a negative opinion.

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources0

Leaning Left1Leaning Right0Center0Last Updated07/26/2024 7:16:22 p.m.Bias Distribution

100% Left

100% Left

Factuality

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)